Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy;Concentración de eritropoyetina en el vítreo de pacientes con retinopatía diabética proliferante

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 3, 2008, Pages 169-172

  Asensio Sanchez V M ^a   Gomez Ramirez V ^a   Morales Gomez I ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Angiogenesis; Diabetes; Erythropoietin; Hypoxia; Neuroprotection; Proliferative diabetic retinopathy

Indexed keywords

ERYTHROPOIETIN;

AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; VITREOUS BODY;

AGED; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; VITREOUS BODY;

EID: 42949121477     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
2. Aiello LP, Avery RL, Arringg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487.
3. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353: 782-792.
4. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, et al. Intravitreal bezacizumab (avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113: 1695-1705.
5. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al. Supresion of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457-19461.
6. Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H. Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport 2004; 15: 877-879.
7. Katsura Y, Okano T, Matsuno K, Osako M, kure M, Watanabe T, et al. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005; 28: 2252-2254.
8. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F Jr, Tabira T, et al. Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of eythroid cells. J Biol Chem 1993; 268: 11208-11216.
9. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997; 76: 105-116.
10. Krantz SB. Erythropoietin. Blood 1991; 77: 419-434.
11. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992; 72: 449-489.
12. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci 2000; 22: 10291-10301.
13. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994; 269: 19488-19493.
14. Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A 1994; 91: 3974-3978.
15. Rondon IJ, MacMillan LA, Beckman BS, et al. Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J Biol Chem 1991; 266: 16594-16598.
16. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-5454.
17. Hernández C, Fonollosa A, García-Ramírez M, Higuera M, Catalán R, Miralles A, et al. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006; 29: 2028-2033.
18. Chow J, Ogunshola O, Fan SY, Li Y, Ment LR, Madri JA. Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res Dev Brain Res 2001; 130: 123-132.
19. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 2002; 51: 472-478.